Posttransplant lymphoproliferative disorder in adult liver transplant recipients: A report of seventeen cases

References

• Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767–1769
   PubMed Web of Science ®Google Scholar
• Gostsschalk S, Rooney C, Heslop H E. Posttransplant lymphoproliferative disorders. Annu Rev Med 2005; 56: 29–44
   PubMed Web of Science ®Google Scholar
• Morrison V A, Dunn D L, Manivel J C, Gajl-Peczalska K J, Peterson B A. Clinical characteristics of posttransplant lymphoproliferative disorders. Am J Med 1994; 97: 14–24
   PubMed Web of Science ®Google Scholar
• Penn I. Immunosuppression—a contributory factor in lymphoma formation. Clin Transplant 1992; 6: 214
   Web of Science ®Google Scholar
• Starzl T E, Nalesnik M A, Porter K A, Ho M, Iwatsuki S, Griffith B P, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583–587
   PubMed Web of Science ®Google Scholar
• Tsai D E, Hardy C, Somer B G, Oltoff K M, Kotloff R M, Tomaszewski J E, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder (PTLD): analysis of prognostic variables and long term follow-up of 42 patients. Transplantation 2001; 1076–1088
   PubMed Web of Science ®Google Scholar
• Dotti G, Fiocchi R, Motta T, Mammana C, Gotti E, Riva S, et al. Lymphoma occuring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation 2002; 74: 1095–1102
   PubMed Web of Science ®Google Scholar
• Mamzer-Bruneel M -F, Lome C, Morelon E, Levy V, Bourquelot P, Jacobs F, et al. Durable remission after aggressive chemotherapy for very late post-kidney transplant proliferation: a report of 16 cases observed in a single center. J Clin Oncol 2000; 18: 3622–3632
   PubMed Web of Science ®Google Scholar
• Swinnen L J, Mullen G M, Carr T J, Costanzo M R, Fisher R I. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86: 3333–3340
   PubMed Web of Science ®Google Scholar
• Elstrom R L, Andreadis C, Aqui N A, Ahya V N, Bloom R D, Brozena S C, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant 2006; 6: 569–576
   PubMed Web of Science ®Google Scholar
• Benkerrou M, Jais J, Leblond V, Durandy A, Sutton L, Bordigoni P, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long term outcome. Blood 1998; 92: 3137–3147
   PubMed Web of Science ®Google Scholar
• Berney T, Delias S, Kato T, Nishida S, Mittal N K, Madariaga J, et al. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 2002; 74: 1000–1006
   PubMed Web of Science ®Google Scholar
• Faye A, Quartier P, Reguerre Y, Lutz P, Carret A S, Dehee A, et al. Chimaeric anti-CD20 monoclonal antibody (rituximab) in posttransplant lymphoproliferative disorder following stem cell transplantation in children. Br J Haemotol 2001; 115: 112–118
   PubMed Web of Science ®Google Scholar
• Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier J L, Niaudet P, et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451–1456
   PubMed Web of Science ®Google Scholar
• Montone K T, Litzky L A, Wurster A, Kaiser L, Bavaria Palevsky H, Pietra G G, Tomaszewski J E. Analysis of Eptein-Barr virus related localized hepatic lymphoproliferative disorders after liver transplantation. Cancer 1996; 76: 1344
   Web of Science ®Google Scholar
• Chen J M, Barr M L, Chadburn A. Management of lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transplant 1993; 6: 570–574
   Google Scholar
• Finn L, Reyes J, Bueno J, Yunis E. Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol 1998; 22: 299–309
   PubMed Web of Science ®Google Scholar
• Mihalov M L, Gattuso P, Abraham K, Holmes E W, Reddy V. Incidence of posttransplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248–255
   PubMed Web of Science ®Google Scholar
• Hanto D W, Frizzera G, Gajl-Peczalska K J, Simmons R L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–472
   PubMed Web of Science ®Google Scholar
• Boubenider S, Hiesse C, Goupe C, Kriaa F, Merchand S, Charpentier B. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 1997; 10: 136–145
   PubMed Web of Science ®Google Scholar
• Nalesnik M A. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transplant Infect Dis 2001; 3: 88–96
   PubMedGoogle Scholar
• Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider B L. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Ped Gastroenterol 2001; 33: 445–449
   PubMed Web of Science ®Google Scholar
• Lee T C, Savoldo B, Barshes N R, Rooney C M, Heslop H E, Gee A P, Caldwell Y, Scott J D, Goss J A. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant 2006; 20: 389–393
   PubMed Web of Science ®Google Scholar
• Choquet S, Leblond V, Herbrecht R, Socie G, Stoppa A M, Vandenberghe P, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative diosrders: results of a prospective multicenter phase 2 study. Blood 2006; 107: 3053–3057
   PubMed Web of Science ®Google Scholar
• Garrett T J, Chadburn A, Barr M L, Drusin R E, Chen J M, Schulman L L, et al. Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin- vincristine-prednisone chemotherapy. Cancer 1993; 72: 2782–2785
   PubMed Web of Science ®Google Scholar
• Newell K A, Millis J, Bruce D S, Woodle E S, Cronin D C, Loss G, et al. An analysis of hepatic retransplantation in children. Transplantation 1998; 65: 1172–1178
   PubMed Web of Science ®Google Scholar
• Wu L, Rappaport D C, Hanbidge A, Merchant N, Shepherd F A, Greig P D. Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging 2001; 26: 200–206
   PubMed Web of Science ®Google Scholar